The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets

Author： Bodovitz S.   Joos T.  

Publisher： Elsevier

ISSN： 0167-7799

Source： Trends in Biotechnology, Vol.22, Iss.1, 2004-01, pp. : 4-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Proteomics: drug target discovery on an industrial scale

By Ryan T.E.   Patterson S.D.  

Trends in Biotechnology, Vol. 20, Iss. 12, 2002-12 ,pp. : 45-51

Elsevier

Access to resources Recommend Favorite

New targets and strategies for the development of antibacterial agents

By Desnottes J.-F.  

Trends in Biotechnology, Vol. 14, Iss. 4, 1996-04 ,pp. : 134-140

Elsevier

Access to resources Recommend Favorite

Peptidoglycan biosynthesis machinery: A rich source of drug targets

By Gautam Ankur   Vyas Rajan   Tewari Rupinder  

Critical Reviews in Biotechnology, Vol. 31, Iss. 4, 2011-12 ,pp. : 295-336

Informa Healthcare

Access to resources Recommend Favorite

Protein Kinases as Drug Targets in Human and Animal Diseases

By  

Current Enzyme Inhibition, Vol. 13, Iss. 2, 2017-06 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs as potential clinical biomarkers: emerging approaches for their detection

By Srivastava SK   Bhardwaj A   Leavesley SJ   Grizzle WE   Singh S   Singh AP  

Biotechnic & Histochemistry, Vol. 88, Iss. 7, 2013-10 ,pp. : 373-387

Informa Healthcare

Access to resources Recommend Favorite